Literature DB >> 20631699

Fighting the monster.

Amy Maxmen.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20631699     DOI: 10.1038/nature09243

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Timing of antiretroviral drugs during tuberculosis therapy.

Authors:  Douglas Wilson; Graeme Meintjes
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

2.  Timing of antiretroviral drugs during tuberculosis therapy.

Authors:  Carolina Garcia-Vidal; Meritxell Salvado; Miguel Salavert
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

3.  Timing of antiretroviral drugs during tuberculosis therapy.

Authors:  Tamilarasu Kadhiravan
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

4.  Timing of initiation of antiretroviral drugs during tuberculosis therapy.

Authors:  Salim S Abdool Karim; Kogieleum Naidoo; Anneke Grobler; Nesri Padayatchi; Cheryl Baxter; Andrew Gray; Tanuja Gengiah; Gonasagrie Nair; Sheila Bamber; Aarthi Singh; Munira Khan; Jacqueline Pienaar; Wafaa El-Sadr; Gerald Friedland; Quarraisha Abdool Karim
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 5.  Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.

Authors:  Stephen D Lawn; Anthony D Harries; Robin Wood
Journal:  Curr Opin HIV AIDS       Date:  2010-01       Impact factor: 4.283

6.  Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.

Authors:  Graeme Meintjes; Stephen D Lawn; Fabio Scano; Gary Maartens; Martyn A French; William Worodria; Julian H Elliott; David Murdoch; Robert J Wilkinson; Catherine Seyler; Laurence John; Maarten Schim van der Loeff; Peter Reiss; Lut Lynen; Edward N Janoff; Charles Gilks; Robert Colebunders
Journal:  Lancet Infect Dis       Date:  2008-08       Impact factor: 25.071

7.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

  7 in total
  2 in total

1.  Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria.

Authors:  Lana Dinic; Patrick Akande; Emmanuel Oni Idigbe; Agatha Ani; Dan Onwujekwe; Oche Agbaji; Maxwell Akanbi; Rita Nwosu; Bukola Adeniyi; Maureen Wahab; Chindak Lekuk; Chioma Kunle-Ope; Nkiru Nwokoye; Phyllis Kanki
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

2.  Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria.

Authors:  Peter Ogie Ikuabe; Ikenna Desmond Ebuenyi
Journal:  Pan Afr Med J       Date:  2018-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.